TP53 and neoplasm: Although the exact impact of specific TP53 alterations in PCa remains to be determined, loss of tumor-suppressive functions of wild-type p53 and mutant p53 gain of function have been described, including direct cross-talk between p53 and androgen receptor signaling pathways [13,14].